MYALGIC ENCEPHALOMYELITIS
Clinical trials for MYALGIC ENCEPHALOMYELITIS explained in plain language.
Never miss a new study
Get alerted when new MYALGIC ENCEPHALOMYELITIS trials appear
Sign up with your email to follow new studies for MYALGIC ENCEPHALOMYELITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an antioxidant help treat chronic fatigue? new trial tests NAC
Disease control OngoingThis Phase 2 trial tests whether N-Acetylcysteine (NAC), an antioxidant, can help people with ME/CFS (chronic fatigue syndrome). Researchers will give 95 participants different doses of NAC or a placebo for four weeks, then measure brain glutathione levels and markers of oxidativ…
Matched conditions: MYALGIC ENCEPHALOMYELITIS
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a low-dose drug help relieve chronic fatigue and Long-COVID?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether low-dose rapamycin can reduce symptoms and improve quality of life in people with ME/CFS or Long-COVID. About 150 participants will take the drug as prescribed by their doctor and complete surveys and blood tests over time. The goal is to see if the dr…
Matched conditions: MYALGIC ENCEPHALOMYELITIS
Sponsor: Simmaron Research Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC